Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Accuray pays $269mm in cash and stock for TomoTherapy

Executive Summary

Accuray Inc. (radiosurgery) is acquiring public radiation treatment company TomoTherapy Inc. for $4.80 per share in cash and stock (a 33% premium), or approximately $269mm. For each outstanding TomoTherapy share, Accuray will pay stockholders $3.15 in cash and issue 0.1648 of an Accuray share.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash
    • Payment Includes Stock

Related Companies